Raised over time
Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine; investor counts may lag the platform by up to a day.
Financials disclosed in this offering
FY2022–FY2023 · hover for sourceThe fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Amendments to this offering
1 amendment- Jan 22, 2025
- Deadline Feb 17, 2025 → Apr 30, 2025
- Target $124K → $20K
“Revised Company Overview; clarified SmileDx (FDA approval pending); added CEO salary plans; extended offering; funding goal now $20,001; updated use of proceeds; added Exhibit F; director inside investments: R. Ricci $49,491, A. Cambria $21,000.”
Form C/A on EDGAR ↗
Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.
Deal terms
Perks
Offering details
Links & provenance
0001665160-24-001634
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.